Segui
Henk van Buuren
Henk van Buuren
Gastroenterologist
Email verificata su erasmusmc.nl
Titolo
Citata da
Citata da
Anno
Population‐based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
K Boonstra, RK Weersma, KJ van Erpecum, EA Rauws, BWM Spanier, ...
Hepatology 58 (6), 2045-2055, 2013
7092013
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study
WJ Lammers, HR van Buuren, GM Hirschfield, HLA Janssen, P Invernizzi, ...
Gastroenterology 147 (6), 1338-1349. e5, 2014
5452014
Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid
EMM Kuiper, BE Hansen, RA de Vries, JW den Ouden–Muller, ...
Gastroenterology 136 (4), 1281-1287, 2009
5432009
Development and validation of a scoring system to predict outcomes of patients with primary biliary cirrhosis receiving ursodeoxycholic acid therapy
WJ Lammers, GM Hirschfield, C Corpechot, F Nevens, KD Lindor, ...
Gastroenterology 149 (7), 1804-1812. e4, 2015
4682015
Lysophosphatidic acid is a potential mediator of cholestatic pruritus
AE Kremer, JJWW Martens, W Kulik, F Ruëff, EMM Kuiper, ...
Gastroenterology 139 (3), 1008-1018. e1, 2010
4562010
High lifetime risk of cancer in primary sclerosing cholangitis
MMH Claessen, FP Vleggaar, KMAJ Tytgat, PD Siersema, HR van Buuren
Journal of hepatology 50 (1), 158-164, 2009
4422009
Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study
F Wolfhagen, E Sternieri, W Hop, G Vitale, M Bertolotti, H van Buuren
Gastroenterology 113 (4), 1264-1269, 1997
3991997
Genome-wide association study identifies variants associated with autoimmune hepatitis type 1
YS De Boer, NMF van Gerven, A Zwiers, BJ Verwer, B van Hoek, ...
Gastroenterology 147 (2), 443-452. e5, 2014
3522014
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions
AE Kremer, R van Dijk, P Leckie, FG Schaap, EMM Kuiper, T Mettang, ...
Hepatology 56 (4), 1391-1400, 2012
2972012
Sclerosing pancreato-cholangitis responsive to steroid therapy
GW Erkelens, FP Vleggaar, W Lesterhuis, HR Van Buuren, ...
The Lancet 354 (9172), 43-44, 1999
2801999
Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+ β‐blocker for prevention of variceal rebleeding
IL Holster, ETTL Tjwa, A Moelker, A Wils, BE Hansen, JR Vermeijden, ...
Hepatology 63 (2), 581-589, 2016
2762016
Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission
NMF van Gerven, BJ Verwer, BI Witte, B van Hoek, MJ Coenraad, ...
Journal of hepatology 58 (1), 141-147, 2013
2562013
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
MH Harms, HR van Buuren, C Corpechot, D Thorburn, HLA Janssen, ...
Journal of Hepatology 71 (2), 357-365, 2019
2372019
Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands
NMF van Gerven, BJ Verwer, BI Witte, KJ van Erpecum, HR van Buuren, ...
Scandinavian journal of gastroenterology 49 (10), 1245-1254, 2014
2352014
High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis
HR van Buuren, HJF van Hoogstraten, T Terkivatan, SW Schalm, ...
Journal of hepatology 33 (4), 543-548, 2000
2242000
Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients
PCJ Ter Borg, SW Schalm, BE Hansen, HR Van Buuren, ...
Official journal of the American College of Gastroenterology| ACG 101 (9 …, 2006
2212006
Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index
C Merkel, M Zoli, S Siringo, H Van Buuren, D Magalotti, P Angeli, ...
Official journal of the American College of Gastroenterology| ACG 95 (10 …, 2000
2122000
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study
PJ Trivedi, WJ Lammers, HR Van Buuren, A Parés, A Floreani, ...
Gut 65 (2), 321-329, 2016
2092016
Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4‐associated cholangitis from primary sclerosing cholangitis
K Boonstra, EL Culver, LM de Buy Wenniger, MJ van Heerde, ...
Hepatology 59 (5), 1954-1963, 2014
1992014
Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome
EMM Kuiper, PE Zondervan, HR Van Buuren
Clinical gastroenterology and hepatology 8 (6), 530-534, 2010
1852010
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20